Duoneb Related Published Studies
Well-designed clinical trials related to Duoneb (Albuterol / Ipratropium)
Comparison of levalbuterol and racemic albuterol combined with ipratropium bromide in acute pediatric asthma: a randomized controlled trial. [2005.07]
The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study. [2005.05]
Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. [2004.10.23]
A short-term comparison of fluticasone propionate/salmeterol with ipratropium bromide/albuterol for the treatment of COPD. [2004]
An evaluation of nebulized levalbuterol in stable COPD. [2003.09]
Addition of ipratropium to nebulized albuterol in children with acute asthma presenting to a pediatric office. [2003.03]
Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. [2001.12]
Standard dose of inhaled albuterol significantly increases QT dispersion compared to low dose of albuterol plus ipratropium bromide therapy in moderate to severe acute asthma attacks in children. [2001.12]
Lower arrythmogenic risk of low dose albuterol plus ipratropium. [2001.10]
Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. [2001.01]
First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department. [2000.06]
Lack of subsensitivity to albuterol after treatment with salmeterol in patients with asthma. [1999.05]
The combination of ipratropium and albuterol optimizes pulmonary function reversibility testing in patients with COPD. [1999.04]
Effect of continuously nebulized ipratropium bromide plus albuterol on emergency department length of stay and hospital admission rates in patients with acute bronchospasm. A randomized, controlled trial. [1999.04]
Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD. [1999.03]
For COPD a combination of ipratropium bromide and albuterol sulfate is more effective than albuterol base. [1999.01.25]
Superiority of ipratropium plus albuterol over albuterol alone in the emergency department management of adult asthma: a randomized clinical trial. [1998.02]
Inhalation by nebulization of albuterol-ipratropium combination (Dey combination) is superior to either agent alone in the treatment of chronic obstructive pulmonary disease. Dey Combination Solution Study Group. [1998]
Effects of inhaled albuterol and ipratropium bromide on autonomic control of the cardiovascular system. [1997.06]
A comparison of ipratropium and albuterol vs albuterol alone for the treatment of acute asthma. [1996.09]
Efficacy of frequent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma. [1995.04]
Efficacy of adding nebulized ipratropium bromide to nebulized albuterol therapy in acute bronchiolitis. [1992.12]
Comparison of ipratropium bromide and albuterol in chronic obstructive pulmonary disease: a three-center study. [1991.10.21]
Additive effect of albuterol and ipratropium bromide in the treatment of bronchospasm in children. [1990.10]
A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease. [1989.03]
Well-designed clinical trials possibly related to Duoneb (Albuterol / Ipratropium)
The efficacy of ketamine in pediatric emergency department patients who present with acute severe asthma. [2005.07]
Comparison of inhaled fluticasone with intravenous hydrocortisone in the treatment of adult acute asthma. [2005.06.01]
Effects of two nebulization regimens on heart rate variability during acute asthma exacerbations in children. [2005.05]
Responsiveness of continuous ratings of dyspnea during exercise in patients with COPD. [2005.04]
Bronchodilators in bronchoscopy-induced airflow limitation in allergen-sensitized cats. [2005.03]
Probabilistic Markov model to assess the cost-effectiveness of bronchodilator therapy in COPD patients in different countries. [2005.01]
Comparison of the effects of ipratropium bromide and salbutamol on autonomic heart rate control. [2004.11]
Adverse effects of short-acting beta-agonists: potential impact when anti-inflammatory therapy is inadequate. [2004.06]
The reversibility of increased airways resistance in chronic heart failure measured by impulse oscillometry. [2004.04]
Nebulized salbutamol vs salbutamol and ipratropium combination in asthma. [2004.02]
Triple inhaled drug protocol for the treatment of acute severe asthma. [2003.06]
A comparison of the effects of salbutamol and ipratropium bromide on exercise endurance in patients with COPD. [2003.06]
Effect of inhalation of salbutamol, beclomethasone dipropionate & ipratropium bromide on mucociliary clearance in some patients with chronic stable bronchial asthma. [2003.04]
A pilot prospective, randomized, placebo-controlled trial of bilevel positive airway pressure in acute asthmatic attack. [2003.04]
Intravenous salbutamol bolus compared with an aminophylline infusion in children with severe asthma: a randomised controlled trial. [2003.04]
Meaningful effect size and patterns of response of the transition dyspnea index. [2003.03]
Bronchodilator premedication does not decrease respiratory adverse events in pediatric general anesthesia. [2003.03]
Efficacy of the novel phosphodiesterase-4 inhibitor BAY 19-8004 on lung function and airway inflammation in asthma and chronic obstructive pulmonary disease (COPD). [2003]
The effect of heliox-driven bronchodilator aerosol therapy on pulmonary function tests in patients with asthma. [2002.10]
Comparison of acute bronchodilator effects of inhaled ipratropium bromide and salbutamol in bronchial asthma. [2002.08]
An evaluation of salmeterol in the treatment of chronic obstructive pulmonary diseases. [2002.07]
What is the optimal treatment strategy for chronic obstructive pulmonary disease exacerbations? [2002.05]
Use of a mucus clearance device enhances the bronchodilator response in patients with stable COPD. [2002.03]
[Benefits of ipratropium bromide in the management of asthmatic crises in the emergency department] [2002.02]
Randomized, double-blind, placebo-controlled trial of intravenous salbutamol and nebulized ipratropium bromide in early management of severe acute asthma in children presenting to an emergency department. [2002.02]
Treatment of patients hospitalized for exacerbations of chronic obstructive pulmonary disease: comparison of an oral/metered-dose inhaler regimen and an intravenous/nebulizer regimen. [2002.02]
Heliox for treatment of exacerbations of chronic obstructive pulmonary disease. [2002]
[RC-Cornet(R) improves the bronchodilating effect of Ipratropiumbromide (Atrovent(R)) inhalation in COPD-patients] [2001.10]
Alternative methods for assessing bronchodilator reversibility in chronic obstructive pulmonary disease. [2001.09]
Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists. [2001.07]
Effectiveness of salmeterol versus ipratropium bromide on exertional dyspnoea in COPD. [2001.06]
Bronchodilatory effects of salbutamol, ipratropium bromide, and their combination: double-blind, placebo-controlled crossover study in cystic fibrosis. [2001.06]
Efficacy of IV theophylline in children with severe status asthmaticus. [2001.05]
In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium : a 3-week, randomized, double-blind, within-patient, multicenter study. [2001.05]
Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease. [2001.04]
The role of domiciliary nebulizers in managing patients with severe COPD. [2001.04]
Regular versus as-needed short-acting inhaled beta-agonist therapy for chronic obstructive pulmonary disease. [2001.01]
[Efficacy of early administration of nebulized ipratropium bromide in children with asthmatic crisis] [2000.09]
Randomized trial of the use of heliox as a driving gas for updraft nebulization of bronchodilators in the emergent treatment of acute exacerbations of chronic obstructive pulmonary disease. [2000.09]
Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium. [2000.05]
Effectiveness and acceptability of a domiciliary multidrug inhalation treatment in elderly patients with chronic airflow obstruction: metered dose inhaler versus jet nebulizer. [2000.03]
Does high dose ipratropium bromide added to salbutamol improve pulmonary function for patients with chronic obstructive airways disease in the emergency department? [2000.02]
[Degree and duration of bronchodilatation with an agonist beta 2 administered alone versus an agonist beta 2 administered with ipratropium bromide in children with acute asthma] [2000.01]
An empirical comparison of the St George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting. [1999.11]
A meta-analysis of the effects of ipratropium bromide in adults with acute asthma. [1999.10]
Rapid improvement of peak flow in asthmatic patients treated with parenteral methylprednisolone in the emergency department: A randomized controlled study. [1999.05]
Efficacy of salmeterol xinafoate in the treatment of COPD. [1999.04]
Ipratropium bromide added to asthma treatment in the pediatric emergency department. [1999.04]
Randomised controlled trial of aminophylline for severe acute asthma. [1998.11]
Effect of nebulized ipratropium on the hospitalization rates of children with asthma. [1998.10.08]
Randomized controlled trial of ipratropium bromide and frequent low doses of salbutamol in the management of mild and moderate acute pediatric asthma. [1998.10]
Comparison of the effects of salmeterol and ipratropium bromide on exercise performance and breathlessness in patients with stable chronic obstructive pulmonary disease. [1998.09]
The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: a pooled analysis of three trials. [1998.08]
How long should Atrovent be given in acute asthma? [1998.05]
Anticholinergic versus beta 2-agonist on gas exchange in COPD: a comparative study in 15 patients. [1998.02]
A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease. [1998.02]
Is it useful to add an anticholinergic treatment to beta 2-adrenergic medication in acute asthma attack? [1998.01]
Efficacy of bronchodilators in the treatment of bronchiolitis. [1997.08]
Nebulized salbutamol with and without ipratropium bromide in the treatment of acute asthma. [1997.08]
Inhibition of PAF-induced gas exchange defects by beta-adrenergic agonists in mild asthma is not due to bronchodilation. [1997.07]
Hospitalization patterns in severe acute asthma in children. [1997.03]
Thermogenic effect of bronchodilators in patients with chronic obstructive pulmonary disease. [1997.02]
The clinical efficacy of combination nebulized anticholinergic and adrenergic bronchodilators vs nebulized adrenergic bronchodilator alone in acute asthma. Canadian Combivent Study Group. [1997.02]
Efficacy of nebulized ipratropium in severely asthmatic children. [1997.02]
Efficacy of bronchodilator therapy in bronchiolitis. A meta-analysis. [1996.11]
Nebulized flunisolide in infants and young children with asthma: a pilot study. [1996.05]
Effects of theophylline and ipratropium on cognition in elderly patients with chronic obstructive pulmonary disease. [1996.04]
Time course of methacholine induced bronchoconstriction during drugs and spontaneous resolution. [1996.03]
Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease. [1996.01.29]
Nebulized bronchodilators for outpatient management of stable chronic obstructive pulmonary disease. [1996.01.29]
A comparison of the bronchodilating effects of salmeterol, salbutamol and ipratropium bromide in patients with chronic obstructive pulmonary disease. [1995.12]
Is an anticholinergic agent superior to a beta 2-agonist in improving dyspnea and exercise limitation in COPD? [1995.09]
Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease. [1995.08]
The influence of an inhaled steroid on quality of life in patients with asthma or COPD. [1995.05]
Continuous and on demand use of bronchodilators in patients with non-steroid dependent asthma and chronic bronchitis: four-year follow-up randomized controlled study. [1995.05]
The incidence of airflow obstruction in bronchial carcinoma, its relation to breathlessness, and response to bronchodilator therapy. [1995.04]
|